Arvinas ARVN Return on invested capital

Return on invested capital at other companies

Nurix Therapeutics, Inc.NRIX

-89.5%+48.4pp

LON

LeonaBio, Inc.LONA

-753.4%+10,346pp

Kymera TherapeuticsKYMR

-32%-6.7pp

Monte Rosa Therapeutics, Inc.GLUE

-53.9%—

Relmada Therapeutics, Inc.RLMD

-49.2%—

ArriVent BioPharma, Inc.AVBP

-75.6%-28.0pp

FAQ

What is Arvinas's return on invested capital?

Arvinas (ARVN) reported return on invested capital of -56.5% in Q1 2026.

How has Arvinas's return on invested capital changed year-over-year?

Arvinas's return on invested capital decreased by 227.7% year-over-year, from -17.2% to -56.5%.

What is the long-term trend for Arvinas's return on invested capital?

Over 5 years (2020 to 2025), Arvinas's return on invested capital has grown at a -18.7% compound annual growth rate (CAGR), from -86.4% to -30.7%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.